WO2012047017A3 - 2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물 - Google Patents
2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물 Download PDFInfo
- Publication number
- WO2012047017A3 WO2012047017A3 PCT/KR2011/007370 KR2011007370W WO2012047017A3 WO 2012047017 A3 WO2012047017 A3 WO 2012047017A3 KR 2011007370 W KR2011007370 W KR 2011007370W WO 2012047017 A3 WO2012047017 A3 WO 2012047017A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- kinase activity
- isoindol
- dihydro
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
본 발명은 화학식 1로 표시되는 화합물 및 약학적으로 허용가능한 그의 염, 수화물, 프로드러그 또는 용매화물을 포함하는, 이상 또는 탈조절된 키나제 활성과 관련된 질병의 치료, 완화 또는 예방용 약학적 조성물에 관한 것으로서, 본 발명의 화합물 및 조성물은 다양한 종류의 단백질 키나제의 활성을 저해함으로써, 이상 또는 탈조절된 키나제 활성과 관련된 질병의 치료, 완화 또는 예방용 유용하게 사용될 수 있다.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38995010P | 2010-10-05 | 2010-10-05 | |
US61/389,950 | 2010-10-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012047017A2 WO2012047017A2 (ko) | 2012-04-12 |
WO2012047017A3 true WO2012047017A3 (ko) | 2012-05-31 |
Family
ID=45928221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2011/007370 WO2012047017A2 (ko) | 2010-10-05 | 2011-10-05 | 2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012047017A2 (ko) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3205654T3 (pl) | 2010-05-20 | 2019-08-30 | Array Biopharma, Inc. | Związki makrocykliczne jako inhibitory kinazy TRK |
US9758508B2 (en) * | 2012-12-28 | 2017-09-12 | Crystalgenomics, Inc. | 2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same |
KR20180041135A (ko) | 2015-07-16 | 2018-04-23 | 어레이 바이오파마 인크. | Ret 키나아제 억제제로서 치환된 피라졸로[1,5-a]피리딘 화합물 |
KR101691954B1 (ko) | 2016-04-26 | 2017-01-02 | 고려대학교 산학협력단 | 신규 n-아실유레아 유도체 및 이를 함유하는 심혈관질환의 예방 또는 치료용 조성물 |
CN105859638B (zh) * | 2016-04-28 | 2018-07-17 | 西安交通大学 | 一种具有抗肿瘤活性的环丁二酰胺化合物及其制备方法和应用 |
CN105924387A (zh) * | 2016-04-28 | 2016-09-07 | 西安交通大学 | 一种具有抗肿瘤活性的双芳基脲化合物及其制备方法和应用 |
CN105906568A (zh) * | 2016-04-28 | 2016-08-31 | 西安交通大学 | 一种具有抗肿瘤活性的环丙二酰胺化合物及其制备方法和应用 |
CN105924403B (zh) * | 2016-04-28 | 2018-07-17 | 西安交通大学 | 一种具有抗肿瘤活性的环丙二酰胺类化合物及其制备方法和应用 |
JOP20190077A1 (ar) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | مركبات بيرازولو [1، 5-a]بيريدين بها استبدال كمثبطات كيناز ret |
TWI704148B (zh) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
CN110267960B (zh) | 2017-01-18 | 2022-04-26 | 阿雷生物药品公司 | 作为RET激酶抑制剂的取代的吡唑并[1,5-a]吡嗪化合物 |
WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
CN110234645A (zh) * | 2017-01-25 | 2019-09-13 | 巴斯夫欧洲公司 | 制备卞型酰胺的方法 |
EP3585778A4 (en) * | 2017-02-21 | 2020-12-02 | Aptose Biosciences Inc. | METHODS OF TREATING PATIENTS WITH HEMATOLOGICAL MALIGNACIES |
JOP20190213A1 (ar) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | مركبات حلقية ضخمة كمثبطات لكيناز ros1 |
TWI812649B (zh) | 2017-10-10 | 2023-08-21 | 美商絡速藥業公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之調配物 |
TWI791053B (zh) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | 6-(2-羥基-2-甲基丙氧基)-4-(6-(6-((6-甲氧基吡啶-3-基)甲基)-3,6-二氮雜雙環[3.1.1]庚-3-基)吡啶-3-基)吡唑并[1,5-a]吡啶-3-甲腈之結晶形式及其醫藥組合物 |
EP3738961B1 (en) * | 2018-01-03 | 2022-08-31 | Medshine Discovery Inc. | Heterocyclic compound as csf-1r inhibitor and use thereof |
JP7061195B2 (ja) | 2018-01-18 | 2022-04-27 | アレイ バイオファーマ インコーポレイテッド | RETキナーゼ阻害剤としての置換ピラゾロ[3,4-d]ピリミジン化合物 |
JP6997876B2 (ja) | 2018-01-18 | 2022-02-04 | アレイ バイオファーマ インコーポレイテッド | Retキナーゼ阻害剤としての置換ピラゾリル[4,3-c]ピリジン化合物 |
CA3087354C (en) | 2018-01-18 | 2023-01-03 | Array Biopharma Inc. | Substituted pyrrolo[2,3-d]pyrimidines compounds as ret kinase inhibitors |
ES2922314T3 (es) | 2018-09-10 | 2022-09-13 | Array Biopharma Inc | Compuestos heterocíclicos condensados como inhibidores de cinasa RET |
AU2019387508A1 (en) * | 2018-11-30 | 2021-06-10 | Aptose Biosciences Inc. | Combination therapy with 2,3-dihydro-isoindole-1-one compounds and methods for treating patients with various mutations |
WO2022212893A1 (en) | 2021-04-02 | 2022-10-06 | Biogen Ma Inc. | Combination treatment methods of multiple sclerosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070161648A1 (en) * | 2005-10-14 | 2007-07-12 | Hughes Terry V | Substituted dihydro-isoindolones useful in treating kinase disorders |
US20090054407A1 (en) * | 2005-04-19 | 2009-02-26 | Kyowa Hakko Kogyo Co., Ltd. | Nitrogen-containing heterocyclic compound |
-
2011
- 2011-10-05 WO PCT/KR2011/007370 patent/WO2012047017A2/ko active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090054407A1 (en) * | 2005-04-19 | 2009-02-26 | Kyowa Hakko Kogyo Co., Ltd. | Nitrogen-containing heterocyclic compound |
US20070161648A1 (en) * | 2005-10-14 | 2007-07-12 | Hughes Terry V | Substituted dihydro-isoindolones useful in treating kinase disorders |
Non-Patent Citations (1)
Title |
---|
HUGHES, T. V. ET AL.: "7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/ VEGF-R2 kinase inhibitors: Design, synthesis, and biological activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 18, no. 18, 2008, pages 5130 - 5133, XP025407688, DOI: doi:10.1016/j.bmcl.2008.07.090 * |
Also Published As
Publication number | Publication date |
---|---|
WO2012047017A2 (ko) | 2012-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012047017A3 (ko) | 2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물 | |
WO2010108074A3 (en) | Inhibitors of pi3 kinase | |
WO2009155121A3 (en) | Inhibitors of pi3 kinase | |
EP2650293A8 (en) | [1,2,4]triazolo[4,3-b][1,2,4]triazine compound, preparation method and use thereof | |
WO2014151871A3 (en) | Jak2 and alk2 inhibitors and methods for their use | |
MX2011011335A (es) | Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina. | |
WO2012162254A8 (en) | Inhibitors of lrrk2 kinase activity | |
TR201906936T4 (tr) | Protein kinaza yönelik inhibitör aktiviteye sahip tiyenopirimidin türevleri. | |
WO2012048129A3 (en) | Inhibitors of polo-like kinase | |
AU2012243329A8 (en) | 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use | |
MX2015008396A (es) | Derivados de la 2,3-dihidro-isoindol-1-ona, como inhibidores de la btk quinasa y composiciones farmacéuticas que los incluyen. | |
UA99141C2 (ru) | Замещенные производные индазола, активные в качестве ингибиторов киназы | |
MX2010006799A (es) | Benzofuropirimidinonas como inhibidores de la proteina cinasa. | |
MX2013011589A (es) | Metodos y composiciones para tratar enfermedad de parkinson. | |
WO2011014795A3 (en) | Compounds and compositions as syk kinase inhibitors | |
MX2008013212A (es) | 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r. | |
UA109868C2 (ru) | Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar) | |
WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
WO2012017239A3 (en) | 4-(1h-indol-3-yl) -pyrimidines as alk inhibitors | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
WO2013188273A8 (en) | Topical ophthalmological pharmaceutical composition containing axitinib | |
WO2013188283A8 (en) | Topical ophthalmological pharmaceutical composition containing sunitinib | |
WO2008131946A3 (de) | Substituierte amid-derivate | |
WO2013188268A8 (en) | Topical ophthalmological pharmaceutical composition containing pazopanib | |
WO2009094560A3 (en) | Thienopyranones as kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11830902 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11830902 Country of ref document: EP Kind code of ref document: A2 |